Journal of Oral Health and Community Dentistry

Register      Login

VOLUME 11 , ISSUE 1 ( January-April, 2017 ) > List of Articles

REVIEW ARTICLE

Healing Effect of Botox in Dental Office

Rakesh Mittal, M Singla, H Aggarwal

Citation Information : Mittal R, Singla M, Aggarwal H. Healing Effect of Botox in Dental Office. J Oral Health Comm Dent 2017; 11 (1):13-18.

DOI: 10.5005/jp-journals-10062-0004

Published Online: 01-01-2017

Copyright Statement:  Copyright © 2017; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

How to cite this article

Mittal R, Singla M, Aggarwal H. Healing Effect of Botox in Dental Office. J Oral Health Comm Dent 2017;11(1):13-18.


PDF Share
  1. BOTOX: broadening the horizon of dentistry. J Clin Diagn Res 2014 Dec;8(12):25–29.
  2. Some vertical linear measurement of lip position. Am J Orthod Dentofac Orthop 1992 Jun;101(6):515–524.
  3. Application of botulinum toxin type A: an arsenal in dentistry. Indian J Dent Res 2011 May-Jun;22(3):440–445.
  4. Erbguth. Historical notes on botulism, Clostridium botulinum, botulinum toxin, and the idea of the therapeutic use of the toxin. Mov Disord 2004 Mar;19(S8):S2–S6.
  5. Uebereinenneuenanaëroben Bacillus und seine Beziehungenzum Botulismus. Zeitschrift Hyg Infektion-skrankheiten 1897;26(1):1–56.
  6. Studies on botulinum toxin: 3. Acid precipitation of botulinum toxin. J Infect Dis 1928;43(2): 152–160.
  7. The action of botulinum toxin on the neuro-muscular junction. J Physiol 1949 Aug;109(1-2):10–24.
  8. Botulinum neurotoxins: from paralysis to recovery of functional neuromuscular transmission. J Physiol (Paris) 2002;96(1-2):105–113.
  9. History of Onabotulinum toxin A. Botulinum toxin. Procedures in cosmetic dermatology. 3rd ed. 2013. p. 1–7.
  10. Evidence for antinociceptive activity of botulinum toxin type A in pain management. Headache 2003 Jul-Aug;43(Suppl 1):S9–S15.
  11. Anal fissure. Dumas Ltd. [cited 2010 Aug 21]. 2006.
  12. Botulinum toxin: mechanisms of action. Eur Neurol 2005 Jan;53(1):3–9.
  13. How Botox works for the treatment of chronic pain. Canada: Canadian Centre for Integrative Medicine; 2009. [cited Aug 2009]. Available from: http://www.drkoprp.com/pdfs/botoxInfo.pdf.
  14. Botulinum toxin in dentistry - the new paradigm for masticatory muscle hypertonicity. Singapore Dent J 2005 Dec;27(1):7–12.
  15. Can Botulinum toxin A (BOTOX) save your teeth and enhance your smile? 2004. [cited 2009]. Available from: http://sci.tech-archive.net/Archive/sci.med.dentistry/2004-06/0484.html.
  16. A Future perspective of Botox in dentofacial region. J Pharm Biomed Sci 2014 Jun;4(6):525–531.
  17. Botulinum toxin in orofacial pain disorders. Dent Clin North Am 2007 Jan;51(1):245–261.
  18. Botulinum toxin and gummy smile - a review. IOSR-JDMS 2013 Jan-Feb;4(1):1–5.
  19. ; Comella, CL.; Brin, MF, editors. Dystonia: etiology, clinical features, and treatment. Philadelphia, PA: Lippincott Williams & Wilkins; 2004. p. 93–112.
  20. Botulinum toxin treatment of temporomandibular disorders, masseteric hypertrophy, and cosmetic masseter reduction. Oper Tech Otolaryngol Head Neck Surg 2004 Jun;15(2):110–113.
  21. The association between head and cervical posture and temporomandibular disorders: a systematic review. J Orofac Pain 2006 Winter;20(1):9–23.
  22. ; Freund, B. Botulinum toxin a therapy for temporomandibular disorders. Philadelphia, PA: Lippincott Williams & Wilkins; 2002.
  23. Treatment of temporomandibular disorders with botulinum toxin. Clin J Pain 2002 Nov-Dec;18(Suppl 6):S198–S203.
  24. Occlusion. In: Kaplan A, Assael L, editors. Temporomandibular disorders. Philadelphia, PA: Saunders; 1992.
  25. Botulinum toxin A is effective in cases of oromandibular dysfunction even if previous bite splint therapy has proved unsuccessful. Cephalalgia 2001 May;21(4):514–515.
  26. The use of botulinum toxin for the treatment of temporomandibular disorders: preliminary findings. J Oral Maxillofac Surg 1999 Aug;57(8):916–921.
  27. Treating severe bruxism with botulinum toxin. Am Dent Assoc 2000 Feb;131(2):211–216.
  28. Botulinum toxin type A injection for the management of myofascial temporomandibular pain disorder. Asian J Oral Maxillofac Surg 2005 Jun;17(2):100–103.
  29. Effect of parafunctional clenching on TMD pain and hearing loss. J Orofacial Pain 1998 Spring;12(2):145–152.
  30. Treatment of bruxism with botulinum toxin injections. J Neurol Neurosurg Psychiatr 1990 Jun;53(6):530.
  31. Botulinum toxin injection for the treatment of oromandibular dystonia. Ann Otol Rhinol Laryngol 1989 Feb;98(2):93–97.
  32. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm. Mov Disord 1987;2(4):237–254.
  33. Treatment of oromandibular dystonia with botulinum toxin. Laryngoscope 1991 Nov;101(11):1216–1218.
  34. Botulinum toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study. Neurology 1987 Apr;37(4):616–623.
  35. Oromandibular dystonia. Clinical forms, diagnosis and examples of therapy with botulinum toxin. Laryngorhinootologie 2001 Dec;80(12):708–713.
  36. Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up. Neurology 1999 Dec;53(9):2102–2107.
  37. Botulinum toxin in case of hemimasticatory spasm with severe worsening during pregnancy. Clin Neuropharmacol 2004 Jan-Feb;27(1):6–8.
  38. Hemimasticatory spasm: clinical and electrophysiologic observations. Neurology 1992 Dec;42(12):2263–2266.
  39. Hemimasticatory spasm associated with localized scleroderma and facial hemiatrophy. Arch Neurol 2000 Apr;57(4):576–580.
  40. A case of hemimasticatory spasm. J Korean Neurol Assoc 1994;12:175–178.
  41. Periodontal parameters of osseointegrated dental implants: a four-year controlled follow-up study. Clin Oral Implants Res 1997 Aug;8(4):272–278.
  42. Botulinum toxin in the treatment of zygomatic fractures. Plast Reconstr Surg 2003 Jan;111(1):341–346.
  43. Botulinums type A (Botox) for the neuromuscular correction of excessive gingival display on smiling (gummy smile). Am J Orthod Dentofacial Orthop 2008 Feb;133(2):195–203.
  44. Botulinum toxin for treatment of masseteric hypertrophy. J Neurol 2002 Mar;249(3):345.
  45. The treatment of masseter hypertrophy with botulinum toxin type A. Saudi Med J 2006 Mar;27(3):397–400.
  46. Treatment of unilateral masseteric hypertrophy with Botulinum toxin: case report. J Oral Maxillofac Surg 1999 Aug;57(8):1017–1019.
  47. Botulinum toxin type A treatment of cosmetically disturbing messetric hypertrophy. Ned Tijdschr Geneeskd 1998 Mar;142(10):529–532.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.